Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates against Trypanosoma and Leishmania

被引：196

作者：

Cavalli, Andrea ^{[1
,2
]}

Bolognesi, Maria Laura ^{[1
]}

机构：

[1] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy

[2] Italian Inst Technol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2009年 / 52卷 / 23期

关键词：

HUMAN AFRICAN TRYPANOSOMIASIS; REDUCTASE-THYMIDYLATE SYNTHASE; FATTY-ACID SYNTHESIS; CHAGAS-DISEASE; DRUG DISCOVERY; VISCERAL LEISHMANIASIS; BRUCEI-RHODESIENSE; SLEEPING SICKNESS; NATURAL-PRODUCTS; METAL-COMPLEXES;

D O I：

10.1021/jm9004835

中图分类号：

R914 [药物化学];

学科分类号：

100705 [微生物与生化药学];

摘要：

[No abstract available]

引用

页码：7339 / 7359

页数：21

共 180 条

[1]

Genomic-scale prioritization of drug targets: the TDR Targets database [J].

Agueero, Fernan ;

Al-Lazikani, Bissan ;

Aslett, Martin ;

Berriman, Matthew ;

Buckner, Frederick S. ;

Campbell, Robert K. ;

Carmona, Santiago ;

Carruthers, Ian M. ;

Chan, A. W. Edith ;

Chen, Feng ;

Crowther, Gregory J. ;

Doyle, Maria A. ;

Hertz-Fowler, Christiane ;

Hopkins, Andrew L. ;

McAllister, Gregg ;

Nwaka, Solomon ;

Overington, John P. ;

Pain, Arnab ;

Paolini, Gala V. ;

Pieper, Ursula ;

Ralph, Stuart A. ;

Riechers, Aaron ;

Roos, David S. ;

Sali, Andrej ;

Shanmugam, Dhanasekaran ;

Suzuki, Takashi ;

Van Voorhis, Wesley C. ;

Verlinde, Christophe L. M. J. .

NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (11) :900-907

[2]

On the origin, evolution, and nature of programmed cell death: a timeline of four billion years [J].

Ameisen, JC .

CELL DEATH AND DIFFERENTIATION, 2002, 9 (04) :367-393

[3]

O-alkoxyamidine prodrugs of furamidine:: In vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection [J].

Ansede, JH ;

Anbazhagan, M ;

Brun, R ;

Easterbrook, JD ;

Hall, JE ;

Boykin, DW .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (17) :4335-4338

[4]

Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations [J].

Aperis, George ;

Mylonakis, Eleftherios .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (06) :579-602

[5]

Drug hybrids enter the fray [J].

Arnaud, Celia Henry .

CHEMICAL & ENGINEERING NEWS, 2007, 85 (46) :46-+

[6]

Inactivation of parasite cysteine proteinases by the NO-donor 4-(phenylsulfonyl)-3-((2-(dimethylamino)ethyl)thio)-furoxan oxalate [J].

Ascenzi, P ;

Bocedi, A ;

Gentile, M ;

Visca, P ;

Gradoni, L .

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1703 (01) :69-77

[7]

Molecular Basis of Antimony Treatment in Leishmaniasis [J].

Baiocco, Paola ;

Colotti, Gianni ;

Franceschini, Stefano ;

Ilari, Andrea .

JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) :2603-2612

[8]

Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo [J].

Balasegaram, Manica ;

Harris, Steve ;

Checchi, Francesco ;

Hamel, Catherine ;

Karunakara, Unni .

BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2006, 84 (10) :777-782

[9]

Network biology:: Understanding the cell's functional organization [J].

Barabási, AL ;

Oltvai, ZN .

NATURE REVIEWS GENETICS, 2004, 5 (02) :101-U15

[10]

Antimalarial dosing regimens and drug resistance [J].

Barnes, Karen I. ;

Watkins, William M. ;

White, Nicholas J. .

TRENDS IN PARASITOLOGY, 2008, 24 (03) :127-134

← 1 2 3 4 5 6 7 8 9 10 →